Form D · Biotechnology
DermOQ, Inc.
Sherman Oaks, CA · CIK 0002010025
Offering snapshot reported Jan 8, 2025 · SEC filing
- Reported sold
- $8.35M Offering amount: $12.4M
- Investors reported
- 80 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 9, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 8, 2025 | Initial | $8,352,108 | No comparison | 80 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $4.07K (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-534640
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Tangent Capital Partners, LLC | 146999 | Ariel Ohana · CRD 7116886 |
Source: Form D, filed Jan 8, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Neel E. Anand | Director |
| Patt E. Bradley | Director, Executive |
| Gerard Camme | Director, Executive |
| Nima E. Gharavi | Director |
| Melissa E. Jochim | Director |
| Frank E. Phillips | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
14930 Ventura Blvd, Ste 325
Sherman Oaks, CA, 91403
Sherman Oaks, CA, 91403